IGC Pharma (IGC) Depreciation & Amortization (CF) (2010 - 2025)
IGC Pharma (IGC) reported Depreciation & Amortization (CF) of $119000.0 for Q3 2025, down 17.93% year-over-year from $145000.0 in Q3 2024, and down 15.6% quarter-over-quarter from $141000.0 in Q2 2025.
IGC Pharma (IGC) Depreciation & Amortization (CF) (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $119000.0 in Q3 2025.
- Depreciation & Amortization (CF) for Q3 2025 came in at $119000.0, down 17.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $260000.0 (down 57.93% YoY), and the FY2026 annual result was $58000.0, down 90.61% from the prior year.
- Depreciation & Amortization (CF) declined to $119000.0 in Q3 2025 per IGC's latest filing, from $141000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $172000.0 in Q4 2022 and troughed at $119000.0 in Q3 2025.
- A 5-year average of $157315.8 and a median of $160000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2021 and 2025: Depreciation & Amortization (CF) jumped 121.33% in 2021, then fell 17.93% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $166000.0 in 2021, then increased by 3.61% to $172000.0 in 2022, then slipped by 6.98% to $160000.0 in 2023, then dropped by 1.88% to $157000.0 in 2024, then fell by 24.2% to $119000.0 in 2025.
- Business Quant data shows IGC's Depreciation & Amortization (CF) at $119000.0 in Q3 2025, $141000.0 in Q2 2025, and $154000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1,395.22 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 429,663.65 |
| 10 | IGC Pharma | 28.11 Mn | 27.85 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 119,000.00 |
| Sep 30, 2025 | 119,000.00 |
| Jun 30, 2025 | 141,000.00 |
| Jun 30, 2025 | 141,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Dec 31, 2024 | 157,000.00 |
| Dec 31, 2024 | 157,000.00 |
| Sep 30, 2024 | 145,000.00 |
| Sep 30, 2024 | 145,000.00 |
| Jun 30, 2024 | 162,000.00 |
| Jun 30, 2024 | 162,000.00 |
| Mar 31, 2024 | 164,000.00 |
| Mar 31, 2024 | 164,000.00 |
| Dec 31, 2023 | 160,000.00 |
| Dec 31, 2023 | 160,000.00 |
| Sep 30, 2023 | 158,000.00 |
| Sep 30, 2023 | 158,000.00 |
| Jun 30, 2023 | 155,000.00 |
| Jun 30, 2023 | 155,000.00 |